布拉格治疗在小鼠结肠癌移植瘤模型中的作用研究
首发时间:2023-05-19
摘要:目的探讨布拉格治疗在小鼠结肠癌移植瘤模型中的作用,并初步探索相关细胞学机制。 方法 在Balb/c小鼠右侧大腿根部皮下及腹腔接种CT26.WT结肠癌细胞,构建结肠癌皮下瘤腹腔转移模型。实验分为对照组(CON)、PD-1抑制剂组(P)、放疗组(Ra)、PD-1抑制剂+放疗组(PRa)、PD-1抑制剂+放疗+GM-CSF组(PRaG)。使用游标卡尺测量皮下瘤长径与短径,计算肿瘤体积。以肿瘤体积>1500mm3作为伦理死亡标准,记录小鼠生存期。流式细胞术检测并分析不同治疗组别外周血中T细胞数量及表型差异、髓源性抑制细胞(MDSCs)亚群数量。 结果相较于CON、P组,PRaG组皮下瘤体积减小(P值分别<0.001、0.01)。相较于CON、PRa组,PRaG组生存期延长(P值均<0.05)。外周血中,相较于CON、Ra、PRa组,PRaG组CD4+ T细胞数量减少(P值均<0.05);相较于CON、Ra组,PRaG组G-MDSCs数量减少(P值均<0.05)。 结论 相较于放疗联合PD-1抑制剂,布拉格治疗具有更显著的抗肿瘤作用,具体的细胞学机制可能与外周血中CD4+ T细胞和G-MDSCs数量减少有关。
For information in English, please click here
Study of effect of PRaG therapy in colon cancer transplanted tumor mouse model
Abstract:Objective: To investigate the effect of PRaG therapy in colon cancer transplanted tumor mouse model and preliminary explore the related cytological mechanism. Methods CT26.WT colon cancer cells were inoculated subcutaneously into the right flank and abdominal cavity of Balb/c mice to establish intraperitoneal metastasis model of colon cancer subcutaneous transplanted tumor. Mice were divided into control group (CON), PD-1 inhibitor group (P), radiotherapy group (Ra), PD-1 inhibitor + radiotherapy group (PRa), and PD-1 inhibitor + radiotherapy +GM-CSF group (PRaG). The long diameter and short diameter of the subcutaneous tumor were measured with vernier caliper, and then we calculate the tumor volume. With tumor volume > 1500mm3 as the standard of ethical death, the survival of mice was recorded. Flow cytometry was used to detect and analyze the number and phenotype of T cells in peripheral blood and the number of myeloid-derived suppressor cells (MDSCs) subsets in different treatment groups. Results Compared with CON and P groups, the volume of subcutaneous tumordecreased in PRaG group (P<0.001, 0.01). Compared with CON and PRa, mice inPRaG group had longer survival (All P<0.05). In peripheral blood, the number of CD4+ T cells in PRaG group decreased compared with CON, Ra and PRa groups (All P<0.05); Compared with CON and Ra groups, the number of G-MDSCs in PRaG group decreased (All P<0.05). Conclusion Compared with radiotherapy combined with PD-1 inhibitor, PRaG therapy has more significantantitumor effect. The specific cytological mechanism may be related to the reduction of CD4+ T cells and G-MDSCs in peripheral blood.?????
Keywords: colon cancer radiotherapy immunotherapy PRaG therapy immune cells
引用

No.****
动态公开评议
共计0人参与
勘误表
布拉格治疗在小鼠结肠癌移植瘤模型中的作用研究
评论
全部评论